Flu season

Last updated

Flu season is an annually recurring time period characterized by the prevalence of an outbreak of influenza (flu). The season occurs during the cold half of the year in each hemisphere. It takes approximately two days to show symptoms. Influenza activity can sometimes be predicted and even tracked geographically. While the beginning of major flu activity in each season varies by location, in any specific location these minor epidemics usually take about three weeks to reach its pinnacle, and another three weeks to significantly diminish. [1]

Contents

Annually, about 3 to 5 million cases of severe illness and 290,000 to 650,000 deaths from seasonal flu occur worldwide. [2]

Cause

Three virus families, Influenza virus A, B, and C are the main infective agents that cause influenza. During periods of cooler temperature, influenza cases increase roughly tenfold or more. Despite the higher incidence of manifestations of the flu during the season, the viruses are actually transmitted throughout populations all year round.[ citation needed ]

Each annual flu season is normally associated with a major influenza virus sub type. The associated sub type changes each year, due to development of immunological resistance to a previous year's strain (through exposure and vaccinations), and mutational changes in previously dormant viruses strains.

The exact mechanism behind the seasonal nature of influenza outbreaks is unknown. Some proposed explanations are:

Research in guinea pigs has shown that the aerosol transmission of the virus is enhanced when the air is cold and dry. [3] The dependence on aridity appears to be due to degradation of the virus particles in moist air, while the dependence on cold appears to be due to infected hosts shedding the virus for a longer period of time. The researchers did not find that the cold impaired the immune response of the guinea pigs to the virus.[ citation needed ]

Research done by the National Institute of Child Health and Human Development (NICHD) in 2008 found that the influenza virus has a butter-like coating. The coating melts when it enters the respiratory tract. In the winter, the coating becomes a hardened shell; therefore, it can survive in the cold weather similar to a spore. In the summer, the coating melts before the virus reaches the respiratory tract. [9]

Timing

Seasonal variation in deaths due to influenza or pneumonia in 122 U.S. cities, as a proportion of all causes CDC-influenza-pneumonia-deaths-2015-01-10.gif
Seasonal variation in deaths due to influenza or pneumonia in 122 U.S. cities, as a proportion of all causes

In the United States, the flu season is considered October through May. [11] It typically reaches an apex in February, [12] with a seasonal baseline varying between 6.1% and 7.7% of all deaths. [10] In Australia, the flu season is considered May to October. It usually peaks in August. [13] For other southern hemisphere countries such as Argentina, Chile, South Africa, and Paraguay also tend to start around June. [14] Brazil has a complex seasonality component for its flu season, due to part of its being in a tropical climate, but its further south latitudes have their flu peaks in June–July, during the southern hemisphere winters. [15]

Flu seasons also exist in the tropics and subtropics, with variability from region to region. [16] In Hong Kong, which has a humid subtropical climate, the flu season runs from December to March, in the winter and early spring. [17] [18]

Flu vaccinations

Flu vaccinations are used to diminish the effects of the flu season and can lower an individual's risk of getting the flu by about half. [19] Since the Northern and Southern Hemisphere have winter at different times of the year, there are actually two flu seasons each year. Therefore, the World Health Organization (assisted by the National Influenza Centers) recommends two vaccine formulations every year; one for the Northern, and one for the Southern Hemisphere. [20]

According to the U.S. Department of Health, a growing number of large companies provide their employees with seasonal flu shots, either at a small cost to the employee or as a free service. [21]

The annually updated trivalent influenza vaccine consists of hemagglutinin (HA) surface glycoprotein components from influenza H3N2, H1N1, and B influenza viruses. [22] The dominant strain in January 2006 was H3N2. Measured resistance to the standard antiviral drugs amantadine and rimantadine in H3N2 has increased from 1% in 1994 to 12% in 2003 to 91% in 2005. [23] [24]

Associated health complications

Pediatric deaths from influenza 2011-2014 - a small fraction of the overall number of flu deaths in the U.S. each year, most of which occur in elderly people CDC-pediatric-influenza-deaths-2015-01.gif
Pediatric deaths from influenza 2011–2014 - a small fraction of the overall number of flu deaths in the U.S. each year, most of which occur in elderly people

Medical conditions that compromise the immune system increase the risks from flu.[ citation needed ]

Diabetes

Millions of people have diabetes. When blood sugars are not well controlled, diabetics can quickly develop a wide range of complications. Diabetes results in elevated blood sugars in the body, and this environment allows viruses and bacteria to thrive.[ citation needed ]

If blood sugars are poorly controlled, a mild flu can quickly turn severe, leading to hospitalization and even death. Uncontrolled blood sugars suppresses the immune systems and generally lead to more severe cases of the common cold or influenza. Thus, it has been recommended that diabetics be vaccinated against flu, before the start of the flu season. [25] [26]

Lung disease

The CDC recommends that people with asthma and chronic obstructive pulmonary disease (COPD) be vaccinated against flu before the flu season. People with asthma can develop life-threatening complications from influenza and the common cold viruses. Some of these complications include pneumonias, acute bronchitis, and acute respiratory distress syndrome. [27]

Each year flu related complications in the USA affect close to 100,000 asthmatics, and millions more are seen in the emergency room because of severe shortness of breath. The CDC recommends that asthmatics are vaccinated between October and November, before the peak of the flu season. Flu vaccines take about two weeks to become effective. [28]

Cancer

People with cancer usually have a suppressed immune system. Moreover, many cancer patients undergo radiation therapy and potent immunosuppressive medications, which further suppresses the body's ability to fight off infections. Everyone with cancer is highly susceptible and is at risk for complications from flu. People with cancer or a history of cancer should receive the seasonal flu shot. Flu vaccination is also strict for lung cancer patients, as cancer leads to complications of pneumonia and bronchitis. People with cancer should not receive the nasal spray vaccine. The flu shot is made up of inactivated (killed) viruses, and the nasal spray vaccines are made up of live viruses. The flu shot is safer for those with a weakened immune system. Those who have received cancer treatment such as chemotherapy and/or radiation therapy within the last month, or have a blood or lymphatic form of cancer should call their doctor immediately if they suspect they may have flu. [29]

HIV/AIDS

Individuals who have HIV/AIDS are prone to a variety of infections. HIV weakens the body's immune system, leaving them vulnerable to viral, bacterial, fungal, and protozoa disorders. People with HIV are at an increased risk of serious flu-related complications. Many reports have shown that individuals with HIV can develop serious pneumonias that need hospitalization and aggressive antibiotic therapy. Moreover, people with HIV have a longer flu season and are at a high risk of death. Vaccination with the flu shot has been shown to boost the immune system and protect against the seasonal flu in some patients with HIV. [30]

Cost

During the 2011-2014 seasons, flu-like illnesses have typically accounted for 6% of outpatient visits at the peak of the season in the United States. CDC-influenza-outpatient-visits-2015-01.gif
During the 2011–2014 seasons, flu-like illnesses have typically accounted for 6% of outpatient visits at the peak of the season in the United States.

The cost of a flu season in lives lost, medical expenses and economic impact can be severe.

In 2017, the World Health Organization (WHO) estimated that the seasonal flu causes 290,000 to 650,000 annual deaths worldwide. [31]

In 2003, the WHO estimated that the cost of flu epidemics in the United States was US$71–167 billion per year. [32] A 2007 study found that annual influenza epidemics in the US result in approximately 600,000 life-years lost, 3 million hospitalized days, and 30 million outpatient visits, resulting in medical costs of $10 billion annually. According to this study, lost earnings due to illness and loss of life amounted to over $15 billion annually and the total economic burden of annual influenza epidemics amounts to over $80 billion. [33] Also, in the US the flu season usually accounts for 200,000 hospitalizations and 41,000 deaths.[ citation needed ]

Because the mortality rate of the H1N1 swine flu is lower than that of common flu strains, this[ clarification needed ] number was actually lower in 2009. According to an article in Clinical Infectious Diseases , published in 2011, the estimated health burden of 2009 Pandemic Influenza A (H1N1), between April 2009 to April 2010, was "approximately 60.8 million cases (range: 43.3–89.3 million), 274,304 hospitalizations (195,086–402,719), and 12,469 deaths (8,868–18,306)" "in the United States due to pH1N1." [34] [35]

Notable occurrences

Seasonal epidemics of influenza can be severe. Some can even rival pandemics in terms of excess mortality. [36] [37] In fact, it is not so much mortality that distinguishes seasonal epidemics from pandemics but rather the extent to which the disease has spread, [38] though the reasons behind this distinction between epidemic and pandemic, as well as the geographic variability observed within individual flu seasons, remain poorly understood. [37] [39] As such, some flu seasons are particularly notable in terms of severity. Others are notable due to other unique or unusual factors, as described below.

According to the United States Public Health Service, "The epidemic of 1928–1929 was the most important since that of 1920", itself considered to be the final wave, at least in the US, of the 1918 pandemic. There were approximately 50,000 excess influenza and pneumonia deaths in the country, or about half of the mortality attributed to the 1920 epidemic. [40]

The 1946–1947 flu season was characterized by a previously unheard of phenomenon. The first influenza vaccine came into use in the 1940s. [41] [42] At this time, the vaccine contained a strain of H1N1 isolated in 1943, and this had been effective during the 1943–1944 and 1944–1945 seasons. During the 1946–1947 season, however, this once-effective vaccine totally failed to protect the military personnel who had received it. [43] A worldwide epidemic occurred, which for a time was considered to have been a pandemic due to its vast spread, albeit a mild one, with relatively low mortality. [44] Antigenetic analysis later revealed that the influenza A virus had undergone intrasubtypic reassortment, in which genes were swapped between two viruses of the same subtype (H1N1), resulting in an extreme drift variant but not an entirely new subtype. [45] [43] The new strains were so different, however, that they were for a time classified into a distinct category, though this distinction has since been lost due to more recent analysis, which supports classifying both the older and the newer strains as influenza A/H1N1. [43] Nevertheless, this experience informed public health experts of the need to update vaccine composition periodically to account for variations in the influenza virus, even if there has been no complete shift in subtype. [46]

The 1950–1951 flu season was particularly severe in England and Wales and in Canada. [36] [37] Influenza A predominated. The rates of excess pneumonia and influenza mortality in these places was higher than those which would later be experienced in both the 1957 and 1968 pandemics. Liverpool in particular experienced a peak in weekly mortality even higher than that of the 1918 pandemic. [37] Northern Europe also experienced severe epidemics this season. [47] [48] By contrast, the United States experienced a relatively milder epidemic. [37] There was no observed shift in the viruses in circulation this flu season. [37]

During the 1952–1953 flu season, the Americas and Europe experienced widespread outbreaks of influenza A. [49] Beginning the first week of January, 1953, influenza in epidemic proportions emerged in various states in the US. Outbreaks soon developed around the country, with Texas experiencing particularly high activity, though the northeast mostly saw smaller, more localized outbreaks. [49] Schools were shuttered in many places due to the high incidence of disease among students and teachers. [49] After an initial attempt to minimize the threat of the outbreak and a resistance to describe it as an "epidemic", [50] [51] the US Public Health Service eventually acknowledged it as such when deaths began to rise around the country. [52] By the end of January, activity was decreasing around the country. [49]

Around the time that the epidemic was peaking in the US, outbreaks developed in France, Germany, and southern England and later in Scandinavia, Switzerland, and Austria; sporadic activity was reported in other parts of Europe. [49] In the US, influenza and pneumonia mortality peaked in early February, earlier than in the three preceding flu seasons, in which mortality did not begin to rise until late February, and was the greatest out of the three preceding seasons, including 1951. [49] It was subsequently found that strains isolated during this season were influenza A but had shifted antigenically relative to previously isolated strains, further demonstrating the significance of antigenic variation in influenza viruses. [53]

The 1967–1968 flu season was the last to be dominated by H2N2 before the emergence of H3N2 in 1968 and the consequent "Hong Kong flu" pandemic that lasted until 1970. This season was particularly severe in England and France, in which pneumonia and influenza excess mortality was two to three times greater than in other countries. [54] By contrast, North America (the US and Canada) experienced a relatively milder epidemic than other places, with lower all-cause excess mortality and a lower increase in both pneumonia-influenza and all-cause excess mortality, both indicating that this season had a lesser impact in North America relative to other countries. [54] In Britain, this epidemic was the "largest" it had experienced in seven years, with an estimated two million cases occurring in the population as a whole. [55]

The 2012–2013 flu season was particularly harsh in the United States, where the majority of states were reporting high rates of influenza-like illness. [56] [57] [58] The Centers for Disease Control and Prevention reported that the available flu vaccine was 60% effective. [58] [59] It further recommended that all persons over age 6 months get the vaccine. [58] [59]

According to one source, the season 2014-2015 saw a particularly heavy prevalence of influenza in the United Kingdom. [60]

See also

Related Research Articles

<span class="mw-page-title-main">Spanish flu</span> 1918–1920 global influenza pandemic caused by the H1N1 influenza A virus

The 1918–1920 flu pandemic, also known as the Great Influenza epidemic or by the common misnomer Spanish flu, was an exceptionally deadly global influenza pandemic caused by the H1N1 subtype of the influenza A virus. The earliest documented case was March 1918 in the state of Kansas in the United States, with further cases recorded in France, Germany and the United Kingdom in April. Two years later, nearly a third of the global population, or an estimated 500 million people, had been infected in four successive waves. Estimates of deaths range from 17 million to 50 million, and possibly as high as 100 million, making it one of the deadliest pandemics in history.

<i>Influenza A virus</i> Species of virus

Influenza A virus (IAV) is the only species of the genus Alphainfluenzavirus of the virus family Orthomyxoviridae. It is a pathogen with strains that infect birds and some mammals, as well as causing seasonal flu in humans. Mammals in which different strains of IAV circulate with sustained transmission are bats, pigs, horses and dogs; other mammals can occasionally become infected.

<span class="mw-page-title-main">Oseltamivir</span> Antiviral medication used against influenza A and influenza B

Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B, viruses that cause the flu. Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. They recommend it to prevent infection in those at high risk, but not the general population. The Centers for Disease Control and Prevention (CDC) recommends that clinicians use their discretion to treat those at lower risk who present within 48 hours of first symptoms of infection. It is taken by mouth, either as a pill or liquid.

<span class="mw-page-title-main">Influenza vaccine</span> Vaccine against influenza

Influenza vaccines, colloquially known as flu shots or the flu jab, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. Vaccination against influenza began in the 1930s, with large-scale availability in the United States beginning in 1945.

The Hong Kong flu, also known as the 1968 flu pandemic, was a flu pandemic that occurred in 1968 and 1969 and which killed between one and four million people globally. It is among the deadliest pandemics in history, and was caused by an H3N2 strain of the influenza A virus. The virus was descended from H2N2 through antigenic shift, a genetic process in which genes from multiple subtypes are reassorted to form a new virus.

<span class="mw-page-title-main">Swine influenza</span> Infection caused by influenza viruses endemic to pigs

Swine influenza is an infection caused by any of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) refers to any strain of the influenza family of viruses that is endemic in pigs. As of 2009, identified SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3.

<span class="mw-page-title-main">Influenza A virus subtype H1N1</span> Subtype of Influenza A virus

Influenza A virus subtype H1N1 (A/H1N1) is a subtype of influenza A virus (IAV). Some human-adapted strains of H1N1 are endemic in humans and are one cause of seasonal influenza (flu). Other strains of H1N1 are endemic in pigs and in birds. Subtypes of IAV are defined by the combination of the antigenic H and N proteins in the viral envelope; for example, "H1N1" designates an IAV subtype that has a type-1 hemagglutinin (H) protein and a type-1 neuraminidase (N) protein.

<span class="mw-page-title-main">Influenza pandemic</span> Pandemic involving influenza

An influenza pandemic is an epidemic of an influenza virus that spreads across a large region and infects a large proportion of the population. There have been five major influenza pandemics in the last 140 years, with the 1918 flu pandemic being the most severe; this is estimated to have been responsible for the deaths of 50–100 million people. The 2009 swine flu pandemic resulted in under 300,000 deaths and is considered relatively mild. These pandemics occur irregularly.

<span class="mw-page-title-main">Influenza A virus subtype H3N2</span> Virus subtype

Influenza A virus subtype H3N2 (A/H3N2) is a subtype of influenza A virus (IAV). Some human-adapted strains of A/H3N2 are endemic in humans and are one cause of seasonal influenza (flu). Other strains of H1N1 are endemic in pigs and in birds. Subtypes of IAV are defined by the combination of the antigenic H and N proteins in the viral envelope; for example, "H1N1" designates an IAV subtype that has a type-1 hemagglutinin (H) protein and a type-1 neuraminidase (N) protein.

<span class="mw-page-title-main">Canine influenza</span> Influenza occurring in canines

Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.

<i>Influenza B virus</i> Species of virus

Influenza B virus is the only species in the genus Betainfluenzavirus in the virus family Orthomyxoviridae.

<span class="mw-page-title-main">Influenza</span> Infectious disease

Influenza, commonly known as the flu, is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin one to four days after exposure to the virus and last for about two to eight days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia from the virus or a subsequent bacterial infection. Other complications include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

<span class="mw-page-title-main">2009 swine flu pandemic</span> 2009–2010 pandemic of swine influenza caused by H1N1 influenza virus

The 2009 swine flu pandemic, caused by the H1N1/swine flu/influenza virus and declared by the World Health Organization (WHO) from June 2009 to August 2010, was the third recent flu pandemic involving the H1N1 virus. The first identified human case was in La Gloria, Mexico, a rural town in Veracruz. The virus appeared to be a new strain of H1N1 that resulted from a previous triple reassortment of bird, swine, and human flu viruses which further combined with a Eurasian pig flu virus, leading to the term "swine flu".

<span class="mw-page-title-main">Pandemic H1N1/09 virus</span> Virus responsible for the 2009 swine flu pandemic

The pandemic H1N1/09 virus is a swine origin influenza A virus subtype H1N1 strain that was responsible for the 2009 swine flu pandemic. This strain is often called swine flu by the public media due to the prevailing belief that it originated in pigs. The virus is believed to have originated around September 2008 in central Mexico.

<span class="mw-page-title-main">2009 swine flu pandemic vaccine</span> Protection against the H1N1/09 virus

The 2009 swine flu pandemic vaccines were influenza vaccines developed to protect against the pandemic H1N1/09 virus. These vaccines either contained inactivated (killed) influenza virus, or weakened live virus that could not cause influenza. The killed virus was injected, while the live virus was given as a nasal spray. Both these types of vaccine were produced by growing the virus in chicken eggs. Around three billion doses were produced, with delivery in November 2009.

Influenza prevention involves taking steps that one can use to decrease their chances of contracting flu viruses, such as the Pandemic H1N1/09 virus, responsible for the 2009 flu pandemic.

During the 1972–1973 flu season in the Northern Hemisphere, a new variant of influenza, dubbed the 'London flu' by the press in the United States, was responsible for epidemics in many countries. 'London flu' was caused by a variant of influenza A/H3N2 that was first isolated in India in mid-1971 but only identified as a distinct strain in England in January, 1972.

<span class="mw-page-title-main">2017–2018 United States flu season</span> 2017–2018 influenza outbreak

The 2017–2018 United States flu season lasted from late 2017 through early 2018. The predominant strain of influenza was H3N2. During the spring months of March–May, influenza B virus became dominant.

<span class="mw-page-title-main">1957–1958 influenza pandemic</span> Pandemic of influenza virus (H2N2)

The 1957–1958 Asian flu pandemic was a global pandemic of influenza A virus subtype H2N2 that originated in Guizhou in Southern China. The number of excess deaths caused by the pandemic is estimated to be 1–4 million around the world, making it one of the deadliest pandemics in history. A decade later, a reassorted viral strain H3N2 further caused the Hong Kong flu pandemic (1968–1969).

Type A influenza vaccine is for the prevention of infection of influenza A virus and also the influenza-related complications. Different monovalent type A influenza vaccines have been developed for different subtypes of influenza A virus including H1N1 and H5N1. Both intramuscular injection or intranasal spray are available on market. Unlike the seasonal influenza vaccines which are used annually, they are usually used during the outbreak of certain strand of subtypes of influenza A. Common adverse effects includes injection site reaction and local tenderness. Incidences of headache and myalgia were also reported with H1N1 whereas cases of fever has also been demonstrated with H5N1 vaccines. It is stated that immunosuppressant therapies would reduce the therapeutic effects of vaccines and that people with egg allergy should go for the egg-free preparations.

References

  1. ↑ "National Institute of Allergy and Infectious Diseases (NIAID) Factsheet". Archived from the original on 2005-10-13. Retrieved 2005-10-08.
  2. ↑ "Influenza (Seasonal)". World Health Organization (WHO). Retrieved 2021-05-10.
  3. 1 2 Lowen, A. C.; Mubareka, S.; Steel, J.; Palese, P. (October 2007). "Influenza virus transmission is dependent on relative humidity and temperature". PLOS Pathogens . 3 (10): 1470–1496. doi: 10.1371/journal.ppat.0030151 . PMC   2034399 . PMID   17953482.
  4. ↑ Shaman, J.; Kohn, M. (March 2009). "Absolute humidity modulates influenza survival, transmission, and seasonality". Proceedings of the National Academy of Sciences of the United States of America . 106 (9): 3243–3248. Bibcode:2009PNAS..106.3243S. doi: 10.1073/pnas.0806852106 . PMC   2651255 . PMID   19204283.
  5. ↑ Shaman, J.; Pitzer, V. E.; Viboud, C.; Grenfell, B. T.; Lipsitch, M. (February 2010). Ferguson, Neil M. (ed.). "Absolute humidity and the seasonal onset of influenza in the continental United States". PLOS Biology . 8 (2): e1000316. doi: 10.1371/journal.pbio.1000316 . PMC   2826374 . PMID   20186267.
  6. ↑ Cannell, J. J.; Vieth, R.; Umhau, J.; Holick, M.; Grant, W.; Madronich, S.; Garland, C.; Giovannucci, E. (2006). "Epidemic influenza and vitamin D". Epidemiology and Infection . 134 (6): 1129–1140. doi:10.1017/S0950268806007175. PMC   2870528 . PMID   16959053.
  7. ↑ Cannel, J. J.; Zasloff, M.; Garland, C. F.; Scragg, R.; Giovannucci, E. (2008). "On the epidemiology of influenza". Virology Journal . 5 (29): 29. doi: 10.1186/1743-422X-5-29 . PMC   2279112 . PMID   18298852.
  8. ↑ Adit, G.; Mansbach, J.; Camargo, C. (2009). "Association Between Serum 25-Hydroxyvitamin D Level and Upper Respiratory Tract Infection in the Third National Health and Nutrition Examination Survey". Archives of Internal Medicine . 169 (4): 384–390. doi:10.1001/archinternmed.2008.560. PMC   3447082 . PMID   19237723.
  9. ↑ Polozov, I. V.; Bezrukov, L.; Gawrisch, K.; Zimmerberg, J. (2008). "Progressive ordering with decreasing temperature of the phospholipids of influenza virus". Nature Chemical Biology . 4 (4): 248–255. doi:10.1038/nchembio.77. PMID   18311130.
  10. 1 2 CDC U.S. influenza season summary with weekly updates See section 'Pneumonia and Influenza (P&I) Mortality Surveillance' www.cdc.gov, accessed 30 September 2020
  11. ↑ "CDC Questions and Answers". 2010-01-27. Archived from the original on 2017-11-21. Retrieved 2010-08-10.
  12. ↑ "CDC: The Flu Season". Archived from the original on 2017-09-11. Retrieved 2017-09-09.
  13. ↑ "Australian Department of Health and Ageing. Australian influenza report 2011". Archived from the original on 2012-05-22. Retrieved 2012-06-03.
  14. ↑ Baumeister E, Duque J, Varela T, Palekar R, Couto P, Savy V, Giovacchini C, Haynes AK, Rha B, Arriola CS, Gerber SI, Azziz-Baumgartner E (January 2019). "Timing of respiratory syncytial virus and influenza epidemic activity in five regions of Argentina, 2007-2016". Influenza and Other Respiratory Viruses. 13 (1): 10–17. doi:10.1111/irv.12596. PMC   6304310 . PMID   30051595.
  15. ↑ Alonso WJ, Viboud C, Simonsen L, Hirano EW, Daufenbach LZ, Miller MA (2007-06-15). "Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics". Am J Epidemiol. 165 (12): 1434–1442. doi: 10.1093/aje/kwm012 . PMID   17369609.
  16. ↑ Moura, Fernanda E. A. (October 2010). "Influenza in the tropics". Current Opinion in Infectious Diseases. 23 (5): 415–420. doi:10.1097/QCO.0b013e32833cc955. ISSN   1473-6527. PMID   20644472. S2CID   206001415.
  17. ↑ Yap, Florence H. Y.; Ho, Pak-Leung; et al. (June 2004). "Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong". Journal of Medical Virology . 73 (4): 617–623. doi:10.1002/jmv.20135. PMID   15221909. S2CID   35385523.
  18. ↑ Wong, Chit-Ming; Chan, King-Pan; Hedley, Anthony Johnson; Peiris, J. S. Malik (December 2004). "Influenza-associated mortality in Hong Kong". Clinical Infectious Diseases . 39 (11): 1611–1617. doi: 10.1086/425315 . hdl: 10722/43588 . PMID   15578360.
  19. ↑ "Flu (Influenza) | Vaccines". www.vaccines.gov. Retrieved 2020-04-30.
  20. ↑ "WHO | WHO recommendations on the composition of influenza virus vaccines". WHO. Archived from the original on 2011-11-12. Retrieved 2020-04-30.
  21. ↑ Knock Out Flu at Work - Washington State Department of Health www.doh.wa.gov, accessed 5 October 2020
  22. ↑ Daum, L. T.; Shaw, M. W.; Klimov, A. I.; Canas, L. C.; Macias, E. A.; Niemeyer, D.; Chambers, J. P.; Renthal, R.; Shrestha, S. K.; Acharya, R. P.; Huzdar, S. P.; Rimal, N.; Myint, K. S.; Gould, P. (August 2005). "Influenza A (H3N2) outbreak, Nepal". Emerging Infectious Diseases . 11 (10): 1186–1191. doi:10.3201/eid1108.050302. PMC   3320503 . PMID   16102305.
  23. ↑ Bailey, Ronald (2005-10-19). "Bird Flu: Threat or Menace? Why avian sniffles need not ruffle our feathers... too much". Archived from the original on 2006-10-26.
  24. ↑ Altman, Lawrence K. (2006-01-15). "This Season's Flu Virus Is Resistant to 2 Standard Drugs". The New York Times . Archived from the original on 2013-05-11. Retrieved 2006-10-30.
  25. ↑ "flu.gov: Diabetes and the Flu". Archived from the original on 2009-10-25. Retrieved 2010-12-12.
  26. ↑ "CDC brochure on flu vaccination for diabetics" (PDF). Archived (PDF) from the original on 2017-05-15. Retrieved 2017-09-09.
  27. ↑ "Flu Season Overview". North Carolina Immunization portal. Archived from the original on 2010-02-16. Retrieved 2010-02-09.
  28. ↑ "HIV/AIDS and the Flu". Centers for Disease Control and Prevention. 2010-02-09. Archived from the original on 2018-12-03. Retrieved 2017-09-09.
  29. ↑ "Cancer and the Flu". Centers for Disease Control and Prevention. Archived from the original on 2017-08-25. Retrieved 2012-11-05.
  30. ↑ "Flu Season 2005-2006: Questions & Answers". MedicineNet. Archived from the original on 2018-12-03. Retrieved 2010-02-09.
  31. ↑ "Up to 650 000 people die of respiratory diseases linked to seasonal flu each year". World Health Organization (WHO). 2017-12-13. Retrieved 2021-05-02.
  32. ↑ "WHO Influenza Overview". Archived from the original on 2009-05-05. Retrieved 2011-10-08.
  33. ↑ Molinari; Ortega-Sanchez; Messonnier; Thompson; Wortley; Weintraub; Bridges (2007), "The annual impact of seasonal influenza in the US: Measuring disease burden and costs", Vaccine, 25 (27): 5086–5096, doi: 10.1016/j.vaccine.2007.03.046 , PMID   17544181
  34. ↑ Shrestha, Sundar S.; Swerdlow, David L.; Borse, Rebekah H.; Prabhu, Vimalanand S.; Finelli, Lyn; Atkins, Charisma Y.; Owus-Edusei, Kwame; Bell, Beth; Mead, Paul S.; Biggerstaff, Matthew; Brammer, Lynnette; Davidson, Heidi; Jernigan, Daniel; Jhung, Michael A.; Kamimoto, Laurie A.; Merlin, Toby L.; Nowell, Mackenzie; Redd, Stephen C.; Reed, Carrie; Schuchat, Anne; Meltzer, Martin I. (2011). "Estimating the Burden of 2009 Pandemic Influenza A (H1N1) in the United States (April 2009–April 2010)". Clinical Infectious Diseases . 52 (suppl 1): S75–S82. doi: 10.1093/cid/ciq012 . PMID   21342903.
  35. ↑ "Flu Season Continues; Severity Indicators Rise". Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD). 2014-01-17. Archived from the original on 2014-01-21. Retrieved 2014-01-24.
  36. 1 2 Viboud, Cécile; Tam, Theresa; Fleming, Douglas; Handel, Andreas; Miller, Mark A.; Simonsen, Lone (2006-11-10). "Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic". Vaccine. 24 (44–46): 6704. doi:10.1016/j.vaccine.2006.05.067. PMID   16806596.
  37. 1 2 3 4 5 6 Viboud, Cécile; Tam, Theresa; Fleming, Douglas; Miller, Mark A.; Simonsen, Lone (April 2006). "1951 Influenza Epidemic, England and Wales, Canada, and the United States". Emerging Infectious Diseases. 12 (4): 667. doi:10.3201/eid1204.050695. PMC   3294686 . PMID   16704816.
  38. ↑ "Epidemic, Endemic, Pandemic: What are the Differences?". Columbia Public Health. 2021-02-12. Retrieved 2022-06-08.
  39. ↑ Tamerius, James; Nelson, Martha I.; Zhou, Steven Z.; Viboud, Cécile; Miller, Mark A.; Alonso, Wladimir J. (2011-04-01). "Global Influenza Seasonality: Reconciling Patterns across Temperate and Tropical Regions". Environmental Health Perspectives. 119 (4): 439–445. doi:10.1289/ehp.1002383. PMC   3080923 . PMID   21097384.
  40. ↑ Collins, Selwyn D. (February 1930). "The Influenza Epidemic of 1928-1929 with Comparative Data for 1918-1919*". American Journal of Public Health. 20 (2): 120. doi:10.2105/ajph.20.2.119. PMC   1555806 . PMID   18012936.
  41. ↑ Weir, J. P.; Gruber, M. F. (2016-03-24). "An overview of the regulation of influenza vaccines in the United States". Influenza and Other Respiratory Viruses. 10 (5): 354–360. doi:10.1111/irv.12383. PMC   4947948 . PMID   27426005.
  42. ↑ Grabenstein, John D.; Pittman, Phillip R.; Greenwood, John T.; Engler, Renata J.M. (2006-06-08). "Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects". Epidemiologic Reviews. 28: 3–26. doi: 10.1093/epirev/mxj003 . PMID   16763072 – via Oxford University Press.
  43. 1 2 3 Kilbourne, Edwin D.; Smith, Catherine; Brett, Ian; Cox, Nancy (2002-08-06). "The total influenza vaccine failure of 1947 revisited: Major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic". Proceedings of the National Academy of Sciences of the United States of America. 99 (16): 10748–10752. Bibcode:2002PNAS...9910748K. doi: 10.1073/pnas.162366899 . PMC   125033 . PMID   12136133.
  44. ↑ Kilbourne, Edwin D. (January 2006). "Influenza Pandemics of the 20th Century". Emerging Infectious Diseases. 12 (1): 11. doi:10.3201/eid1201.051254. PMC   3291411 . PMID   16494710.
  45. ↑ Zimmer, Shanta M.; Burke, Donald S. (2009-06-29). "Historical Perspective — Emergence of Influenza A (H1N1) Viruses". New England Journal of Medicine. 361 (3): 281. doi: 10.1056/NEJMra0904322 . PMID   19564632.
  46. ↑ Rasmussen, A. F. Jr.; Stokes, J. C.; Smadel, J. E. (March 1948). "THE ARMY EXPERIENCE WITH INFLUENZA, 1946–1947". American Journal of Epidemiology. 47 (2): 142–149. doi:10.1093/oxfordjournals.aje.a119191. PMID   18908909 – via Oxford University Press.
  47. ↑ Isaacs, A.; Gledhill, A. W.; Andrewes, C. H. (1952). "Influenza A viruses". Bulletin of the World Health Organization. 6 (2): 287–315. hdl:10665/266181. ISSN   0042-9686. PMC   2554045 . PMID   12988024.
  48. ↑ Isaacs, A.; Andrewes, C. H. (1951-10-20). "The Spread Of Influenza: Evidence From 1950-1951". The British Medical Journal. 2 (4737): 921–927. doi:10.1136/bmj.2.4737.921. JSTOR   25376729. PMC   2070559 . PMID   14869766.
  49. 1 2 3 4 5 6 Davis, Dorland J.; Dauer, Carl C. (December 1953). "The Occurrence of Influenza In the United States, 1952-53". Public Health Reports. 68 (12): 1141–1146. doi:10.2307/4588662. JSTOR   4588662. PMC   2024453 . PMID   13121173.
  50. ↑ "FLU 'SPREAD MINIMIZED". The New York Times. 1953-01-11. p. 75. Retrieved 2022-06-08.
  51. ↑ "U. S. FLU EPIDEMIC MILD". The New York Times. 1953-01-24. p. 17. Retrieved 2022-06-08.
  52. ↑ "U. S. NOTES FLU DEATHS". The New York Times. 1953-01-30. p. 11. Retrieved 2022-06-08.
  53. ↑ Isaacs, A.; Depoux, R.; Fiset, P. (1954). "The viruses of the 1952-3 influenza epidemic". Bulletin of the World Health Organization. 11 (6): 967–979. hdl:10665/265957. ISSN   0042-9686. PMC   2542214 . PMID   14364180.
  54. 1 2 Viboud, Cécile; Grais, Rebecca F.; Lafont, Bernard A. P.; Miller, Mark A.; Simonsen, Lone (2005-07-15). "Multinational Impact of the 1968 Hong Kong Influenza Pandemic: Evidence for a Smoldering Pandemic". The Journal of Infectious Diseases. 192 (2): 233–248. doi: 10.1086/431150 . ISSN   0022-1899. PMID   15962218.
  55. ↑ Miller, D. L.; Lee, J. A. (1969). "Influenza in Britain 1967–68". Journal of Hygiene. 67 (3): 559–572. doi:10.1017/S0022172400042005. PMC   2130729 . PMID   5258229.
  56. ↑ Szabo, Liz; Vergano, Dan; Weise, Elizabeth (2013-01-11). "Flu widespread in 47 states". USA Today . McLean, VA: Gannett. ISSN   0734-7456. Archived from the original on 2013-01-12. Retrieved 2013-01-11.
  57. ↑ Szabo, Liz (2013-01-11). "Questions and Answers: Flu season hits U.S." USA Today . McLean, VA: Gannett. ISSN   0734-7456. Archived from the original on 2013-01-11. Retrieved 2013-01-11.
  58. 1 2 3 "As the flu spreads across the country, Boston declares an emergency". Consumer Reports . 2013-01-10. Archived from the original on 2013-01-13. Retrieved 2013-01-10.
  59. 1 2 "Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013" (PDF). cdc.gov. 2013-01-11. Archived (PDF) from the original on 2013-01-20. Retrieved 2013-01-11.
  60. ↑ "Coronavirus: How to understand the death toll". BBC News. 2020-04-16. Retrieved 2020-05-27.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.